ScoreWhy is Moberg Pharma AB ?
1
The company declared negative results in Dec'24 after very positive results in Sep'24
- NET PROFIT(9M) At SEK -253.47 MM has Grown at -1,392.06%
- RAW MATERIAL COST(Y) Grown by 29.18% (YoY)
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -41.78%, its profits have fallen by -1019.7%
3
Below par performance in long term as well as near term
- Along with generating -41.78% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Moberg Pharma AB for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Moberg Pharma AB
-41.78%
-0.87
73.16%
OMX Stockholm 30
8.01%
0.44
18.11%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
68.29%
EBIT Growth (5y)
-254.35%
EBIT to Interest (avg)
-81.88
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.01
Tax Ratio
20.49%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.23%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.58
EV to EBIT
-0.44
EV to EBITDA
-0.44
EV to Capital Employed
0.34
EV to Sales
11.57
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-76.27%
ROE (Latest)
-37.48%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK -13.61 MM
NET SALES(HY)
At SEK 7.46 MM has Grown at 51.45%
PRE-TAX PROFIT(Q)
At SEK -8.7 MM has Grown at 89%
NET PROFIT(Q)
At SEK -7.39 MM has Grown at 88.23%
CASH AND EQV(HY)
Highest at SEK 523.64 MM
-5What is not working for the Company
NET PROFIT(9M)
At SEK -253.47 MM has Grown at -1,392.06%
RAW MATERIAL COST(Y)
Grown by 29.18% (YoY
Here's what is working for Moberg Pharma AB
Pre-Tax Profit
At SEK -8.7 MM has Grown at 89%
over average net sales of the previous four periods of SEK -79.04 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (SEK MM)
Net Profit
At SEK -7.39 MM has Grown at 88.23%
over average net sales of the previous four periods of SEK -62.85 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (SEK MM)
Net Sales
At SEK 7.46 MM has Grown at 51.45%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (SEK MM)
Operating Cash Flow
Highest at SEK -13.61 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Cash and Eqv
Highest at SEK 523.64 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Moberg Pharma AB
Raw Material Cost
Grown by 29.18% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
